"In this preliminary uncontrolled case series of 5 critically ill patients with COVID-19 and ARDS, administration of convalescent plasma containing neutralizing antibody was followed by improvement in the patients’ clinical status. The limited sample size and study design preclude a definitive statement about the potential effectiveness of this treatment, and these observations require evaluation in clinical trials."

"In this preliminary uncontrolled case series of 5 critically ill patients with COVID-19 and ARDS, administration of convalescent plasma containing neutralizing antibody was followed by improvement in the patients’ clinical status. The limited sample size and study design preclude a definitive statement about the potential effectiveness of this treatment, and these observations require evaluation in clinical trials."

- March 27, 2020

https://jamanetwork.com/journals/jama/fullarticle/2763983?guestAccessKey=74708c98-751a-40f1-a047-17c34f7d18ec&utm_source=twitter&utm_medium=social_jama&utm_term=3230728525&utm_campaign=article_alert&linkId=85235233